NYS Council Comments in Response to DEA Proposed Rules

March 30, 2023

Earlier today the NYS Council submitted our comments in response to the DEA’s recently published Proposed Rules in the Federal Register regarding telemedicine prescribing of controlled substances, including buprenorphine, in anticipation of the end of the COVID-19 public health emergency (PHE).

See two documents.

DEA Telemedicine Comment Ltr – NYS Council

DEA Buprenorphine Comment Ltr – NYS Council